Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Finland

European Innovation Council · Running

PMed Enabling patient specific medicines using 3D printing in hospitals and pharmacies

Coordinator
Curifylabs Oy, Finland
Runs
1 September 2023 to 31 August 2025
Status
Running
EU funding
€2.5m
Total cost
€3.5m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190157849

What the project is doing

In the project's own words, from its summary on CORDIS.

Uniform drug treatments are not always the best option for treating some patient populations – including children and the elderly. The industry now has extensive knowledge on the benefits of personalized medicines that take the age, metabolic and genetic differences of patients into account. However, until now there has not been a practical manufacturing solution to put this knowledge into wide-scale use. CurifyLabs has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in the pharmacies and bring industry level standards to mass customisation of medicines.

In this project we will finalize a standard process for developing 3D printing compatible formulations and quality control solutions. This will make MiniLab highly scalable across different therapeutic areas.

Topics

Who is involved

OrganisationCityCountryRole
Curifylabs OyHelsinskiFinlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI